Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Gelderblom

Showing results (1-10 of 488) with videos related to

Pageof 49
Sort By:
British Journal of Cancer|March 25, 2021
No need for H<sub>2</sub>-antagonists in premedication regimens for paclitaxel infusions: less is moreHans Gelderblom, Juliette Zwaveling
Expert Opinion on Investigational Drugs|November 30, 2020
Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenibMahmoud Mohammadi, Hans Gelderblom
Current Opinion in Oncology|May 15, 2014
Current clinical trials for advanced osteosarcoma and soft tissue sarcomaStefan Sleijfer, Hans Gelderblom
Investigational New Drugs|May 7, 2011
The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecanMarije Slingerland, Hans Gelderblom
Expert Opinion on Investigational Drugs|December 5, 2008
Diflomotecan, a promising homocamptothecin for cancer therapyJudith R Kroep, Hans Gelderblom
Clinical Sarcoma Research|October 11, 2014
Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case seriesArie J Verschoor, Hans Gelderblom
Sarcoma|October 2, 2013
Osteosarcoma: lessons learned and future avenuesAjay Puri, Norman Jaffe, Hans Gelderblom
Future Oncology (London, England)|July 24, 2020
Pexidartinib: first approved systemic therapy for patients with tenosynovial giant cell tumorHans Gelderblom, Michiel van de Sande
Clinical Sarcoma Research|November 9, 2016
Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case seriesAstrid Lipplaa, Sander Dijkstra, Hans Gelderblom
Sarcoma|June 20, 2013
Osteosarcoma: evolution of treatment paradigmsNorman Jaffe, Ajay Puri, Hans Gelderblom
Pageof 49

Showing results (1-10 of 488) with videos related to

Sort By:
Pageof 49
British Journal of Cancer|March 25, 2021
No need for H<sub>2</sub>-antagonists in premedication regimens for paclitaxel infusions: less is moreHans Gelderblom, Juliette Zwaveling
Expert Opinion on Investigational Drugs|November 30, 2020
Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenibMahmoud Mohammadi, Hans Gelderblom
Current Opinion in Oncology|May 15, 2014
Current clinical trials for advanced osteosarcoma and soft tissue sarcomaStefan Sleijfer, Hans Gelderblom
Investigational New Drugs|May 7, 2011
The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecanMarije Slingerland, Hans Gelderblom
Expert Opinion on Investigational Drugs|December 5, 2008
Diflomotecan, a promising homocamptothecin for cancer therapyJudith R Kroep, Hans Gelderblom
Clinical Sarcoma Research|October 11, 2014
Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case seriesArie J Verschoor, Hans Gelderblom
Sarcoma|October 2, 2013
Osteosarcoma: lessons learned and future avenuesAjay Puri, Norman Jaffe, Hans Gelderblom
Future Oncology (London, England)|July 24, 2020
Pexidartinib: first approved systemic therapy for patients with tenosynovial giant cell tumorHans Gelderblom, Michiel van de Sande
Clinical Sarcoma Research|November 9, 2016
Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case seriesAstrid Lipplaa, Sander Dijkstra, Hans Gelderblom
Sarcoma|June 20, 2013
Osteosarcoma: evolution of treatment paradigmsNorman Jaffe, Ajay Puri, Hans Gelderblom
Pageof 49